Tech Company Financing Transactions
Batu Biologics Funding Round
Private investors participated in a $1 million Seed capital raise for Batu Biologics. This venture round was announced on 6/23/2015.
Transaction Overview
Company Name
Announced On
6/23/2015
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to advance its lead program ValloVax.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9255 Towne Centre Dr. 450
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Batu Biologics is a biotechnology-based pharmaceutical company focused on the development and commercialization of novel therapies that target the Achilles Heel of cancer: the tumor blood vessels.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Ichim
Chief Financial Officer
Gerry Berg
Browse more venture capital transactions:
Prev: 6/23/2015: Arena Online venture capital transaction
Next: 6/23/2015: DigitalGenius venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs